b) v ostatních případech po předchozím schválení revizním lékařem.
| 517.1 | V08AB02 | iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 184,90 | K |
| 517.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 159,40 | K |
| 517.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 220,90 | K |
| 517.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 122,70 | K |
| 517.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,50 | K |
| 517.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 256,70 | K |
| 517.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 142,65 | K |
| 517.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 207,20 | K |
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 159,40 | K |
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 236,91 | K |
| 59544 | HEXABRIX 320 | inj sol 1x50ml | GUT | F |
| 59545 | HEXABRIX 320 | inj sol 25x50ml | GUT | F |
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 242,54 | K |
| 517.13 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 299,78 | K |
| 517.14 | V08AB04 | opamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,92 | K |
| 517.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,67 | K |
| 517.16 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 365,98 | K |
| 517.17 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 224,93 | K |
| 517.18 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 181,10 | K |
| 517.19 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 122,70 | K |
| 517.20 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,40 | K |
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 142,60 | K |
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,80 | K |
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 429,71 | K/P |
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 534,28 | K/P |
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 95,60 | K |
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) parent. | 10 | ML | 122,70 | K | |
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 256,70 | K |
| 517.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,40 | K |
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 142,65 | K |
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML 149,50 | K | |
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 207,20 | K |
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 159,42 | K |
| 517.33 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 193,90 | K |
| 42400 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | ABH | N |
| 42401 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | AHC | IRL |
| 42402 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | ABH | N |
| 42403 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | AHC | IRL |
| 45115 | VISIPAQUE 150 MG l/ML | inj sol 6x200ml-skl | AHC | IRL |
| 84340 | VISIPAQUE 150 MG l/ML | inj sol 6x200ml-skl | ABH | N |
| 42398 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | ABH | N |
| 42399 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | AHC | IRL |
| 517.34 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 302,90 | K |
| 517.35 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 253,90 | K |
| 42410 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | ABH | N |
| 42411 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | AHC | IRL |
| 45120 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-sk | AHC | IRL |
| 84343 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-sk | ABH | N |
| 42412 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | ABH | N |
| 42413 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | AHC | IRL |
| 42414 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | ABH | N |
| 42415 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | AHC | IRL |
| 42416 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | ABH | N |
| 42417 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | AHC | IRL |
| 45121 | VISIPAQUE 270 MG l/ML | inj sol 6x200ml-skl | AHC | IRL |
| 84344 | VISIPAQUE 270 MG l/ML | inj sol 6x200ml-skl | ABH | N |
| 42418 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | ABH | N |
| 42419 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | AHC | IRL |
| 42406 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | ABH | N |
| 42407 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | AHC | IRL |
| 517.36 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 321,70 | K |
| 517.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 258,50 | K |
| 42438 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | ABH | N |
| 42439 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | AHC | IRL |
| 45125 | VISIPAQUE 320 MG l/ML | inj sol 6x200ml-skl | AHC | URL |
| 84348 | VISIPAQUE 320 MG l/ML | inj sol 6x200ml-skl | ABH | N |
| 42440 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | ABH | N |
| 42441 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | AHC | IRL |
| 42428 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | ABH | N |
| 517.38 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 92,70 | K |
| 517.39 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 109,70 | K |
| 517.40 | V08AB10 | iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 126,00 | K |
| 517.41 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,50 | K |
| 517.42 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 142,65 | K |
| 517.43 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 207,20 | K |
| 517.44 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 159,40 | K |
| 517.45 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli vöetne) | parent. | 10 | ML | 228,70 | K |
| 517.46 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 175,90 | K |
| 517.47 | V08AB11 | lobitridol (koncentrace 300 mg nad 50 ml v ampuli) | parent. | 10 | ML | 142,65 | K |
| 517.48 | V08AB11 | lobitridol (koncentrace 350 mg nad 50 ml v ampuli) | parent. | 10 | ML | 159,40 | K |
| 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. |
|---|
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10 | ML | 74,25 | K |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10 | ML | 37,39 | K |
| 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 39,35 | K |
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. |
|---|
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 ML | 462,54 | K | |
| 59494 | LIPIODOL ULTRA-FLUIDE | inj sol 1x10ml | GUT | F |
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. |
|---|
| 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 32,15 | K |
| 59062 | MICROPAQUE | sus 1x2000ml | DEF | F |
| 95607 | MICROPAQUE | sus 1x2000ml | GUT | F |
| 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 147,52 | K |
| 62399 | E-Z-CAT | sus 1x225ml | EZE | USA |
| 78269 | E-Z-CAT | sus 1x225ml | EZE | CND |
| 46675 | MICROPAQUE CT | sus 1x2000ml/100gm | DEF | F |
| 95609 | MICROPAQUE CT | sus 1x2000ml/100gm | GUT | F |
| 520.3 | V08BA01 | RTG kontrastní přípravky obsahující síran barnatý (lékové formy kolon) | p.rect. | 100 | GM | 45,00 | K |
| 20926 | MICROPAQUE COLON | rct plv sus 1x800gm | GUE | F |
| 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K |
| 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 36,73 | K |
| 59063 | MICROPAQUE H.D. ORAL | plv 1x416gm | DEF | F |
| 95610 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUT | F |
| 521 | V08CA | paramagnetické kontrastní látky | parent. |
|---|
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1582,80 | K |
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1472,10 | K |
| 521.3 | V08CA02 | meglumin gadoterat do 10 ml v jedné ampuli včetně | parent. | 10 | ML | 1582,80 | K |
| 521.4 | V08CA02 | meglumin gadoterat nad 10 ml v jedné ampuli | parent. | 10 | ML | 1472,10 | K |
| 521.5 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1582,80 | K |
| 521.6 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1472,10 | K |
| 521.7 | V08CA04 | gadoteridol (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1582,80 | K |
| 521.8 | V08CA04 | gadoteridol (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1472,10 | K |
| 521.9 | V08CA05 | mangafodipir | parent. | 10 | ML | 916,70 | K |
| 521.10 | V08CA08 | dimeglumin gadobenat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1582,80 | K |
| 521.11 | V08CA08 | dimeglumin gadobenat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1472,10 | K |
| 521.12 | V08CA09 | gadobutrol, koncentrace do 0,5 mmol/l včetně | parent. | 10 | ML | 1472,10 | K |
| 521.13 | V08CA09 | gadobutrol, koncentrace nad 0,5 mmol/l | parent. | 10 | ML | 2208,10 | K |
| 521.14 | V08CB03 | oxid železa, nanočástice, s obsahem do 0,9 ml včetně | parent. | 1 | DF | 5780,78 | H |
| 521.15 | V08CB03 | oxid železa, nanočástice, s obsahem nad 0,9 ml | parent. | 1 | DF | 6700,00 | H |
| 521.16 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1 | DF | 2857,50 | H |
| 521.17 | V08DA02 | mikročástice galaktózy | parent. | 1 | GM | 914,00 | H |